Abstract
Lithium, the first element of Group I in the periodic system, is used to treat bipolar psychiatric disorders. Lithium chloride (LiCl) is a selective inhibitor of glycogen synthase kinase-3β (GSK-3β), a serine/threonine kinase that regulates many cellular processes, in addition to its role in the regulation of glycogen synthase. GSK-3β is emerged as a promising drug target for various neurological diseases, type-2 diabetes, cancer, and inflammation. Several works have demonstrated that lithium can either inhibit or stimulate growth of normal and cancer cells. Hence, the present study is focused to analyze the underlying mechanisms that dictate the biphasic oncogenic properties of LiCl. In the current study, we have investigated the dose-dependent effects of LiCl on human breast cancer cells (MCF-7) by assessing the consequences on cytotoxicity and protein expressions of signaling molecules crucial for the maintenance of cell survival. The results showed breast cancer cells respond in a diverse manner to LiCl, i.e., at lower concentrations (1, 5, and 10 mM), LiCl induces cell survival by inhibiting apoptosis through regulation of GSK-3β, caspase-2, Bax, and cleaved caspase-7 and by activating anti-apoptotic proteins (Akt, β-catenin, Bcl-2, and cyclin D1). In contrast, at high concentrations (50 and 100 mM), it induces apoptosis by reversing these effects. Moreover, LiCl also alters the sodium and potassium levels thereby altering the membrane potential of MCF-7 cells. Thus it is inferred that LiCl exerts a dose-dependent biphasic effect on breast cancer cells (MCF-7) by altering the apoptotic/anti-apoptotic balance.
Similar content being viewed by others
Abbreviations
- ANOVA:
-
Analysis of variance
- Bax:
-
Bcl2-associated X protein 1
- Bcl-2:
-
B cell lymphoma 2
- CM:
-
Conditioned medium
- DMEM:
-
Dulbecco's modified Eagle's medium
- ECF:
-
Extracellular fluid
- EDTA:
-
Ethylenediaminetetraacetic acid
- FBS:
-
Fetal bovine serum
- GSK-3β:
-
Glycogen synthase kinase-3β
- LiCl:
-
Lithium chloride
References
Weiner ML (1991) Overview of lithium toxicology. In: Schrauzer GN, Klippel KF (eds) Lithium in biology and medicine. Weinheim, VCH, pp 83–99
Dawson EB (1991) The relationship of tap water and physiological levels of lithium to mental hospital admission and homicide in Texas. In: Schrauzer GN, Klippel KF (eds) Lithium in biology and medicine. Weinheim, VCH, pp 171–187
Okusa MD, Crystal LJ (1994) Clinical manifestations and management of acute lithium intoxication. Am J Med 97:383–389
Ellenhorn MJ, Schonwald S, Ordog G, Wasserberger J (1997) Lithium. In: Ellenhorn MJ, Schonwald S, Ordog G, Wasserberger J (eds) Medical toxicology: diagnosis and treatment of human poisoning. Williams and Wilkins, Baltimore, p 1579
Henry GC (1998) Lithium. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Weisman RS, Howland MA, Hoffman RS (eds) Toxicologic emergencies. Appleton and Lange, Stamford, p 969
Ward ME, Musa MN, Bailey L (1994) Clinical pharmacokinetics of lithium. J Clin Pharmacol 34:280–285
Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci 93:8455–8459. doi:10.1073/pnas.93.16.8455
Ryves WJ, Harwood AJ (2001) Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem Biophys Res Commun 280:720–725
Jope RS, Johnson GV (2004) The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 29:95–102
Welshons WV, Engler KS, Taylor JA, Grady LH, Curran EM (1995) Lithium-stimulated proliferation and alteration of phosphoinositide metabolites in MCF-7 human breast cancer cells. J Cell Physiol 165:134–144
Kang HJ, Noh JS, Bae YS, Gwag BJ (2003) Calcium-dependent prevention of neuronal apoptosis by lithium ion: essential role of phosphoinositide 3-kinase and phospholipase C gamma. Mol Pharmacol 64:228–234
Chuang DM (2005) The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann N Y Acad Sci 1053:195–204
Rao AS, Kremenevskaja N, Resch J, Brabant G (2005) Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/beta-catenin signalling. Eur J Endocrinol 153:929–938
Chen CL, Lin CF, Chiang CW, Jan MS, Lin YS (2006) Lithium inhibits ceramide- and etoposide-induced protein phosphatase 2A methylation, Bcl-2 dephosphorylation, caspase-2 activation, and apoptosis. Mol Pharmacol 70:510–517
Sinha D, Wang Z, Ruchalski KL, Levine JS, Krishnan S, Lieberthal W, Schwartz JH, Borkan SC (2005) Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am J Physiol Renal 288:F703–F713
Gustin JP, Karakas B, Weiss MB, Abukhdeir AM, Lauring J, Garay JP, Cosgrove D, Tamaki A, Konishi H, Konishi Y, Mohseni M, Wang G, Rosen DM, Denmeade SR, Higgins MJ, Vitolo MI, Bachman KE, Park BH (2009) Knocking of mutant PIK3CA activates multiple oncogenic pathways. Proc Natl Acad Sci 106:2835–2840
Erdal E, Ozturk N, Cagatay T, Eksioglu-Demiralp E, Ozturk M (2005) Lithium-mediated downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular carcinoma cells. Int J Cancer 115:903–910
Song L, Zhou T, Jope RS (2004) Lithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptor. BMC Neurosci 5:20
Tang HR, He Q (2003) Effects of lithium chloride on the proliferation and apoptosis of K562 leukemia cells. Hunan Yi Ke Da Xue Xue Bao 28:357–360
Tseng WP, Lin-Shiau SY (2002) Long-term lithium treatment prevents neurotoxic effects of beta-bungarotoxin in primary cultured neurons. J Neurosci Res 69:633–641
Gelfand EW, Dosch NH, Hastings D, Shore A (1979) Lithium: a modulator of cyclic AMP-dependent levels in lymphocytes. Science 203:365–367
Hart DA (1979) Potentiation of phytohemagglutinin stimulation of lymphoid cells by lithium. Exp Cell Res 121:419–425
Avissar S, Schreiber G, Danon A, Belmaker RH (1988) Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331:440–442
Drummond AH (1988) Lithium affects G-protein receptor coupling. Nature 331:388
Ziaie Z, Kefalides NA (1989) Lithium chloride restores host protein synthesis in herpes simplex virus-infected endothelial cells. Biochem Biophys Res Commun 160:1073–1078
Madiehe AM, Mampuru LJ, Tyobeka EM (1995) Induction of apoptosis in HL-60 cells by lithium. Biochem Biophys Res Commun 209:768–774
Inaba K, Utsugi J, Kuroda T, Tsuda M, Tsuchiya T (1997) Na+(Li+)/H+ antiporter in Pseudomonas aeruginosa and effect of Li+ on cell growth. Biol Pharm Bull 20:621–624
Oliveira AG, Soares MJ, Pinto AS (1997) Ultrastructural alterations induced by lithium chloride in DNA-containing organelles of a bat trypanosome. Mem Inst Oswaldo Cruz 92:513–516
Tomooka Y, Imagawa W, Nandi S, Bern HA (1983) Growth effect of lithium on mouse mammary epithelial cells in serum-free collagen gel culture. J Cell Physiol 117:290–296
Nakamura CV, Pinto AS (1989) Biological effects of lithium chloride on the insect trypanosomatid Herpetomonas samuelpessoai. Parasitology 2:193–197
Hori C, Oka T (1979) Induction by lithium ion of multiplication of mouse mammary epithelium in culture. Proc Natl Acad Sci 76:2823–2827
Ptashne K, Stockdale FE, Conlon S (1980) Initiation of DNA synthesis in mammary epithelium and mammary tumors by lithium ions. J Cell Physiol 103:41–46
Rybak SM, Stockdale FE (1981) Growth effects of lithium chloride in BALB/c 3T3 fibroblasts and Madin–Darby canine kidney epithelial cells. Exp Cell Res 136:263–270
Polotsky AJ, Zhu L, Santoro N, Pollard JW (2009) Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometrium. Hum Reprod 24:1960–1967
Ballin A, Aladjem M, Banyash M, Boichis H, Barzilay Z, Gal R, Witz IP (1983) The effect of lithium chloride on tumour appearance and survival of melanoma-bearing mice. Br J Cancer 48:83–87
Sun A, Shanmugam I, Song J, Terranova PF, Thrasher JB, Li B (2007) Lithium suppresses cell proliferation by interrupting E2F-DNA interaction and subsequently reducing S-phase gene expression in prostate cancer. Prostate 9:976–988
Zaragosi LE, Wdziekonski B, Fontaine C, Villageois P, Peraldi P, Dani C (2008) Effects of GSK3 inhibitors on in vitro expansion and differentiation of human adipose-derived stem cells into adipocytes. BMC Cell Biol 9:11
Stump RJ, Lovicu FJ, Ang SL, Pandey SK, McAvoy JW (2006) Lithium stabilizes the polarized lens epithelial phenotype and inhibits proliferation, migration, and epithelial mesenchymal transition. J Pathol 210:249–257
Laurenz JC, Smith SB (1998) Lithium chloride does not inhibit the proliferation of L6 myoblasts by decreasing intracellular free inositol. J Anim Sci 76:66–73
Suganthi M, Sangeetha G, Benson CS, Dinesh Babu S, Sathyavathy A, Sivakumar R, Ravi Sankar B (2012) In vitro mechanisms involved in the regulation of cell survival by lithium chloride and IGF-1 in human hormone-dependent breast cancer cells (MCF-7). Toxicol Lett 214:182–191
Sahebgharani M, Nejati M, Sepehrizadeh Z, Khorramizadeh MR, Bahrololoumi-Shapourabadi M, Hashemi-Bozchlou S, Esmaeili J, Ghazi-Khansari M (2008) Lithium chloride protects PC12 pheochromocytoma cell line from morphine-induced apoptosis. Arch Iran Med 11:639–648
Stambolic V, Ruel L, Woodgett JR (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6:1664–1668
Doble BW, Woodgett JR (2003) GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116:1175–1186
Cohen P, Frame S (2001) The renaissance of GSK3. Nat Rev Mol Cell Biol 2:769–776
Silva AK, Yi H, Hayes SH, Seigel GM, Hackam AS (2010) Lithium chloride regulates the proliferation of stem-like cells in retinoblastoma cell lines: a potential role for the canonical Wnt signaling pathway. Mol Vis 16:36–45
Tell S, Yi H, Jockovich ME, Murray TG, Hackam AS (2006) The Wnt signaling pathway has tumor suppressor properties in retinoblastoma. Biochem Biophys Res Commun 349:261–269
Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K, Eilers R, Dienes HP, Schirmacher P (2003) Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. J Pathol 201:250–259
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790
van Es JH, Giles RH, Clevers HC (2001) The many faces of the tumor suppressor gene APC. Exp Cell Res 264:126–134
Roh MS, Hong SH, Jeong JS (2004) Gene expression profiling of breast cancers with emphasis of β-catenin regulation. J Korean Med Sci 19:275–282
Lin SY, Xia W, Wang JC (2000) β-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci 97:4262–4266
Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426
Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ (2000) WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. Genes Dev 14:585–595
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512
Bartkova J, Lukas J, Müller H, Lüzhoft D, Strauss M, Bartek J (1994) Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 57:353–361
Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL, Steeg PS (1995) Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat Med 1:1257–1260
Courjal F, Louason G, Speiser P, Katsaros D, Zeillinger R, Theillet C (1996) Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int J Cancer 69:247–253
Michalides R, Hageman P, van Tinteren H, Houben L, Wientjens E, Klompmaker R, Peterse J (1996) A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. Br J Cancer 73:728–734
Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA (1994) Function of a human cyclin gene as an oncogene. Proc Natl Acad Sci 91:709–713
Lovec H, Sewing A, Lucibello FC, Müller R, Möröy T (1994) Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 9:323–326
Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV (1994) Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669–671
Diehl JA, Cheng M, Roussel MF, Sherr CJ (1998) Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499–3511
Takahashi-Yanaga F, Sasaguri T (2008) GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy. Cell Signal 20:581–589
Schotte P, Van Loo G, Carpentier I, Vandenabeele P, Beyaert R (2001) Lithium sensitizes tumor cells in an NF-kappa B-independent way to caspase activation and apoptosis induced by tumor necrosis factor (TNF). Evidence for a role of the TNF receptor-associated death domain protein. J Biol Chem 276:25939–25945
Liao X, Zhang L, Thrasher JB, Du J, Li B (2003) Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer. Mol Cancer Ther 2:1215–1222
Yin XM (2000) Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways. Cell Res 10:161–167
Mohamad N, Gutierrez A, Nunez M et al (2005) Mitochondrial apoptotic pathways. Biocell 29:149–161
Orrenius S, Gogvadze V, Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47:143–183
Chen RW, Chuang DM (1999) Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem 274:6039–6042
Bauer JH, Helfand SL (2006) The humble fly: what a model system can reveal about the human biology of aging. Med Health R I 89:314–315
Hartley CE, Buchan A, Randall S, Skinner GR, Osborne M, Tomkins LM (1993) The effects of lithium and potassium on macromolecular synthesis in herpes simplex virus-infected cells. J Gen Virol 74:1519–1525
Coppen A, Shaw DM (1967) The distribution of electrolytes and water in patients after taking lithium carbonate. Lancet 2:805–806
Gow IF, Ellis D (1990) Effect of lithium on the intracellular potassium concentration in sheep heart Purkinje fibres. Exp Physiol 75:427–430
Acknowledgments
One of the authors (M. Suganthi) acknowledge on of the authors the financial support for this study from UGC-Research Fellowships in Sciences for Meritorious Students (UGC-RFSMS) programme. This study is financially supported by UGC-Special Assistance Programme (UGC-SAP), New Delhi, India.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suganthi, M., Sangeetha, G., Gayathri, G. et al. Biphasic Dose-Dependent Effect of Lithium Chloride on Survival of Human Hormone-Dependent Breast Cancer Cells (MCF-7). Biol Trace Elem Res 150, 477–486 (2012). https://doi.org/10.1007/s12011-012-9510-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-012-9510-x